- Home
- NVS vs MS Comparison
NVS vs MS Comparison
Compare NVS & MS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVS
- MS
- Stock Information
- Founded
- NVS 1895
- MS 1924
- Country
- NVS Switzerland
- MS United States
- Employees
- NVS N/A
- MS N/A
- Industry
- NVS Biotechnology: Pharmaceutical Preparations
- MS Investment Bankers/Brokers/Service
- Sector
- NVS Health Care
- MS Finance
- Exchange
- NVS Nasdaq
- MS Nasdaq
- Market Cap
- NVS 230.5B
- MS 202.7B
- IPO Year
- NVS 1991
- MS N/A
- Fundamental
- Price
- NVS $99.09
- MS $123.43
- Analyst Decision
- NVS Hold
- MS Buy
- Analyst Count
- NVS 6
- MS 16
- Target Price
- NVS $121.25
- MS $127.29
- AVG Volume (30 Days)
- NVS 1.1M
- MS 5.6M
- Earning Date
- NVS 01-31-2025
- MS 01-16-2025
- Dividend Yield
- NVS 3.81%
- MS 3.00%
- EPS Growth
- NVS 130.53
- MS 17.45
- EPS
- NVS 8.58
- MS 6.57
- Revenue
- NVS $49,940,000,000.00
- MS $58,282,000,000.00
- Revenue This Year
- NVS $10.04
- MS $15.22
- Revenue Next Year
- NVS $4.55
- MS $5.27
- P/E Ratio
- NVS $11.28
- MS $18.80
- Revenue Growth
- NVS 8.92
- MS 9.18
- 52 Week Low
- NVS $92.35
- MS $83.09
- 52 Week High
- NVS $120.92
- MS $136.24
- Technical
- Relative Strength Index (RSI)
- NVS 46.34
- MS 42.92
- Support Level
- NVS $98.53
- MS $125.46
- Resistance Level
- NVS $100.67
- MS $129.95
- Average True Range (ATR)
- NVS 0.98
- MS 2.69
- MACD
- NVS 0.54
- MS -0.06
- Stochastic Oscillator
- NVS 65.73
- MS 32.44
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
About MS Morgan Stanley
Morgan Stanley is a global investment bank whose history, through its legacy firms, can be traced back to 1924. The company has institutional securities, wealth management, and investment management segments with approximately 45% of net revenue from its institutional securities business, 45% from wealth management, and 10% from investment management. About 30% of its total revenue is from outside the Americas. The company had over $5 trillion of client assets as well as around 80,000 employees at the end of 2023.